Form D · Pharmaceuticals
Archer Pharmaceuticals, Inc.
Sarasota, FL · CIK 0001450856
Offering snapshot reported Dec 9, 2008 · SEC filing
- Reported sold
- $2.7M Offering amount: $25M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 9, 2008 | Initial | $2,700,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-124829
Source: Form D, filed Dec 9, 2008. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Arena | Executive |
| Geoff Birkett | Director |
| Fiona Crawford | Executive |
| Steven Ford | Director |
| Michael Mullan | Director, Executive |
| Robert Roskamp | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2040 Whitfield Avenue
Sarasota, FL, 34243
Sarasota, FL, 34243